Delivery Order SPE2DB24D2012-SPE2DB25FBVMH
Award Date 3/11/25
Potential Completion Date 3/12/25
Potential Value $1.5K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,778.62, is for the delivery of Moxifloxacin HCL 400 mg tablets. The contract is a Firm Fixed Price Delivery Order with a period of performance through July 10, 2024. This award is not designated as a set-aside contract. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC)...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,094.28, is a firm fixed-price delivery order to provide 4,565,047,008 units of the medication Moxifloxacin HCL 400 mg Tablet. The ultimate completion date for this contract is July 2, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,307.14, is for the delivery of moxifloxacin HCL 400 mg tablets. It is a firm fixed-price delivery order contract with a completion date of February 18, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $4,118.26, is for the delivery of moxifloxacin hydrochloride 400 mg tablets. It is a Firm Fixed Price Delivery Order contract with a period of performance through March 20, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite...
- This federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical was issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Moxifloxacin HCL 400 mg tablets. The $5,425.11 firm fixed-price contract has a completion date of September 6, 2024. Amerisourcebergen holds a large Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive range of...
- This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,345.50 firm fixed-price delivery order is for the supply of 4,564,783,446 units of the antibiotic medication moxifloxacin hydrochloride 400 mg tablets. The contract has a completion date of June 4, 2024. Amerisourcebergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The award is for the delivery of moxifloxacin, a 400 mg/250 ml antibiotic medication, with a ceiling value of $1,075.38 and an ultimate completion date of September 3, 2024. This contract is a delivery order under a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,585.38 firm fixed-price delivery order is for the supply of Moxifloxacin Hydrochloride, a broad-spectrum antibiotic medication. The contract has an ultimate completion date of February 7, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,823.63, is a Firm Fixed Price Delivery Order for the procurement of 4566527432 MOXIFLOXACIN HCL 400 MG TABLET 30S. The contract has an ultimate completion date of November 25, 2024 and was awarded on November 22, 2024. The contract does not have a set-aside designation, indicating open...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4565418587 - Moxifloxacin HCL 400 mg Tablets in bottles of 30. The award, valued at $1,891.35, is a delivery order contract with a firm fixed price. The contract has an ultimate completion date of August 13, 2024. Amerisourcebergen Drug Corp's Corporate Office Division is the prime contractor, and there is no set-aside designation...